Page last updated: 2024-12-05

ethamoxytriphetol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Ethamoxytriphetol: A non-steroidal estrogen antagonist. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6222
CHEMBL ID47647
CHEBI ID34748
SCHEMBL ID330094
MeSH IDM0007818

Synonyms (45)

Synonym
NCI60_001651
1-(4-{[2-(diethylamino)ethyl]oxy}phenyl)-2-[4-(methyloxy)phenyl]-1-phenylethanol
mer-25
benzeneethanol, alpha-(4-(2-(diethylamino)ethoxy)phenyl)-4-methoxy-alpha-phenyl-
1-(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-anisylethanol
1-(4-(2-diethylaminoethoxy)phenyl)-1-phenyl-2-(p-anisyl)ethanol
brn 2017765
ethanol, 1-(p-(2-(diethylamino)ethoxy)phenyl)-2-(p-methoxyphenyl)-1-phenyl-
1-(p-(2-(diethylamino)ethoxy)phenyl)-1-phenyl-2-(p-methoxyphenyl)ethanol
ai3-50793
nsc 19857
ethamoxytriphetol
wln: 2n2&2or dxqr&1r do1
67-98-1
nsc-19857
ethanoxytriphetol
mer 25
1-[4-(2-diethylaminoethoxy)phenyl]-1-phenyl-2-(p-anisyl)ethanol
1-[p-[2-(diethylamino)ethoxy]phenyl]-1-phenyl-2-(p-methoxyphenyl)ethanol
nsc19857 ,
ethanol, 1-[p-[2-(diethylamino)ethoxy]phenyl]-2-(p-methoxyphenyl)-1-phenyl-
benzeneethanol, .alpha.-[4-[2-(diethylamino)ethoxy]phenyl]-4-methoxy-.alpha.-phenyl-
(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-anisylethanol
benzeneethanol, {.alpha.-[4-[2-(diethylamino)ethoxy]phenyl]-4-methoxy-.alpha.-pheny} l-
1-[4-(2-diethylaminoethyloxy)phenyl]-2-(4-methoxyphenyl)-1-phenyl-ethanol
{1-[p-[2-(diethylamino)ethoxy]phenyl]-1-phenyl-2-(p-methoxyphenyl)e} thanol
1-(4-(2-(diethylamino)ethoxy)phenyl)-2-(4-methoxyphenyl)-1-phenylethanol
ethanol, {1-[p-[2-(diethylamino)ethoxy]phenyl]-2-(p-methoxyphenyl)-1-phenyl-}
{1-[4-(2-diethylaminoethoxy)phenyl]-1-phenyl-2-(p-anisyl)ethanol}
4-methoxy-alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylbenzeneethanol
CHEMBL47647
chebi:34748 ,
unii-2nd166f554
2nd166f554 ,
SCHEMBL330094
1-(p-(2-diethylaminoethoxy)phenyl)-2-(p-methoxyphenyl)-1-phenylethanol
benzeneethanol, .alpha.-(4-(2-(diethylamino)ethoxy)phenyl)-4-methoxy-.alpha.-phenyl-
DTXSID6020806
AKOS030584230
Q25091482
1-{4-[2-(diethylamino)-ethoxy]phenyl}-2-(4-methoxyphenyl)-1-phenylethanol
nsc 19857;mer 25
1-[4-[2-(diethylamino)ethoxy]phenyl]-2-(4-methoxyphenyl)-1-phenylethanol
PD011679
alpha-[4-[2-(diethylamino)ethoxy]phenyl]-4-methoxy-alpha-phenylbenzeneethanol

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Pregnant baboons were untreated (n = 8) or received MER-25 orally at a dosage of 25 (n = 10), 50 (n = 8), or 75 (n = 4) mg/kg BW daily on Days 140-170 of gestation (term = 184 days)."( Regulation of placental low-density lipoprotein uptake in baboons by estrogen: dose-dependent effects of the anti-estrogen ethamoxytriphetol (MER-25).
Albrecht, ED; Henson, MC; Pepe, GJ, 1991
)
0.49
" Oral administration of the estrogen antagonist MER-25 at two dosage levels (15 and 30 mg/kg/day) to the pregnant baboon from days 35 to 55 after conception results in a decline in peripheral plasma levels of progesterone within a few days and persists for at least 20 days after the termination of treatment with no effect on plasma estradiol levels."( The effect of estrogen antagonism on progesterone production in early pregnancy in the baboon (Papio cynocephalus).
Castracane, VD; Goldzieher, JW; Kuehl, TJ, 1983
)
0.27
" Animals born of mothers given the highest dosage of the drug (400 microgram) weighed less than controls in adulthood."( Deleterious effects of prenatal prednisolone exposure upon morphological and behavioral development of mice.
Gandelman, R; Rosenthal, C, 1981
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
stilbenoidAny olefinic compound characterised by a 1,2-diphenylethylene backbone.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID127057Ability to antagonize uterine weight gain in immature mice, at a dose of 150 ug; Activity is expressed as anti-uterotrophic % reduction1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Synthesis and biological evaluation of a series of 1,1-dichloro-2,2,3-triarylcyclopropanes as pure antiestrogens.
AID127060Ability to antagonize uterine weight gain in immature mice, at a dose of 30 ug; Activity is expressed as anti-uterotrophic % reduction1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Synthesis and biological evaluation of a series of 1,1-dichloro-2,2,3-triarylcyclopropanes as pure antiestrogens.
AID136774Percentage reduction in estradiol-stimulated uterotrophic effect of immature mice at 150 ug1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
Molecular structures and conformational studies of triarylcyclopropyl and related nonsteroidal antiestrogens.
AID69058Percent relative binding affinity (RBA) for estrogen receptor compared to estradiol1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
Molecular structures and conformational studies of triarylcyclopropyl and related nonsteroidal antiestrogens.
AID127063Antagonism of estradiol induced uterine weight gain in immature mice at 750 ug; Activity is expressed as anti-uterotrophic % reduction1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Synthesis and biological evaluation of a series of 1,1-dichloro-2,2,3-triarylcyclopropanes as pure antiestrogens.
AID69536Relative binding affinity evaluated from the ability to displace [3H]estradiol from estrogen receptor in rat uterine cytosol preparation.1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Synthesis and biological evaluation of a series of 1,1-dichloro-2,2,3-triarylcyclopropanes as pure antiestrogens.
AID21911Estrogenic property of the compound; nonestrogenic1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
Molecular structures and conformational studies of triarylcyclopropyl and related nonsteroidal antiestrogens.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (71)

TimeframeStudies, This Drug (%)All Drugs %
pre-199057 (80.28)18.7374
1990's11 (15.49)18.2507
2000's3 (4.23)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other73 (98.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]